Neutrophil-to-ferritin Ratio Can Predict Hematological Causes of Fever of Unknown Origin

Overview

Journal Sci Rep

Specialty Science

Date 2024 Oct 3

PMID 39362941

Authors

Hikmet Oztop

Fazil Cagri Hunutlu

Affiliations

Soon will be listed here.

Abstract

Despite advancements in diagnostic modalities, delineating the etiology of fever of unknown origin (FUO) remains a significant challenge for clinicians. Notably, cases with hematological malignancies often have a poor prognosis due to delayed diagnosis. This study investigated the potential of readily obtainable laboratory markers to differentiate hematological causes from other etiologies during the early stages of FUO. A retrospective analysis was conducted on the medical records of 100 patients who fulfilled the modified FUO criteria between January 2010 and April 2023. Hematological etiologies were identified in 26 of the 100 patients. Peripheral blood neutrophil, lymphocyte, platelet counts, and the systemic immune inflammation (SII) index, were significantly lower in the hematological group compared to the non-hematological group. Conversely, serum ferritin levels were demonstrably higher in the hematological group. ROC analysis identified a neutrophil-to-ferritin ratio (NFR) cutoff value of < 8.53 as optimal for predicting hematological etiology. Subsequent multivariate analysis demonstrated that the NFR was the sole independent predictor of hematological etiology (p = 0.013).This study proposes a novel approach for early diagnosis of a potentially life-threatening subset of FUO patients. The NFR presents as an inexpensive and readily available marker for predicting hematological etiology in FUO cases.

References

Petersdorf R, Beeson P . Fever of unexplained origin: report on 100 cases. Medicine (Baltimore). 1961; 40:1-30. DOI: 10.1097/00005792-196102000-00001. View

Kucukardali Y, Oncul O, Cavuslu S, Danaci M, Calangu S, Erdem H . The spectrum of diseases causing fever of unknown origin in Turkey: a multicenter study. Int J Infect Dis. 2007; 12(1):71-9. DOI: 10.1016/j.ijid.2007.04.013. View

Mourad O, Palda V, Detsky A . A comprehensive evidence-based approach to fever of unknown origin. Arch Intern Med. 2003; 163(5):545-51. DOI: 10.1001/archinte.163.5.545. View

Cunha B, Lortholary O, Cunha C . Fever of unknown origin: a clinical approach. Am J Med. 2015; 128(10):1138.e1-1138.e15. DOI: 10.1016/j.amjmed.2015.06.001. View

ARNOW P, Flaherty J . Fever of unknown origin. Lancet. 1997; 350(9077):575-80. DOI: 10.1016/S0140-6736(97)07061-X. View

Halder R, Seth T, Chaturvedi P, Mishra P, Mahapatra M, Pati H . Comparison of CRP and procalcitonin for etiological diagnosis of fever during febrile neutropenia in hematology patients- an experience from a tertiary care center in Northern India. Blood Cells Mol Dis. 2020; 84:102445. DOI: 10.1016/j.bcmd.2020.102445. View

Xu T, Wang L, Wu S, Zhou F, Huang H . Utility of a Simple Scoring System in Differentiating Bacterial Infections in Cases of Fever of Unknown Origin. Clin Infect Dis. 2020; 71(Suppl 4):S409-S415. DOI: 10.1093/cid/ciaa1520. View

Wan L, Gao Y, Yang C, Gu J, Liu T, Hu Q . Differential diagnostic performance of PET/CT in adult-onset still's disease and lymphoma: a retrospective pilot study. Quant Imaging Med Surg. 2023; 13(1):37-48. PMC: 9816740. DOI: 10.21037/qims-22-246. View

Kim S, Kim U, Jang M, Kang S, Jang H, Jung S . Diagnostic use of serum ferritin levels to differentiate infectious and noninfectious diseases in patients with fever of unknown origin. Dis Markers. 2013; 34(3):211-8. PMC: 3810234. DOI: 10.3233/DMA-130962. View

10.

Ganz T, Nemeth E . Iron sequestration and anemia of inflammation. Semin Hematol. 2009; 46(4):387-93. PMC: 2755591. DOI: 10.1053/j.seminhematol.2009.06.001. View

11.

Shi L, Wang X, Yan C . Prognostic Value of Systemic Inflammation Score for Esophageal Cancer Patients Undergoing Surgery: A Systematic Review and Meta-Analysis. J Invest Surg. 2023; 36(1):2197058. DOI: 10.1080/08941939.2023.2197058. View

12.

Nemeth E, Valore E, Territo M, Schiller G, Lichtenstein A, Ganz T . Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood. 2002; 101(7):2461-3. DOI: 10.1182/blood-2002-10-3235. View

13.

Zandman-Goddard G, Shoenfeld Y . Ferritin in autoimmune diseases. Autoimmun Rev. 2007; 6(7):457-63. DOI: 10.1016/j.autrev.2007.01.016. View

14.

Wright W, Auwaerter P . Fever and Fever of Unknown Origin: Review, Recent Advances, and Lingering Dogma. Open Forum Infect Dis. 2020; 7(5):ofaa132. PMC: 7237822. DOI: 10.1093/ofid/ofaa132. View

15.

Zhao M, Ruan Q, Xing M, Wei S, Xu D, Wu Z . A Diagnostic Tool for Identification of Etiologies of Fever of Unknown Origin in Adult Patients. Curr Med Sci. 2019; 39(4):589-596. DOI: 10.1007/s11596-019-2078-3. View

16.

Daver N, McClain K, Allen C, Parikh S, Otrock Z, Rojas-Hernandez C . A consensus review on malignancy-associated hemophagocytic lymphohistiocytosis in adults. Cancer. 2017; 123(17):3229-3240. PMC: 5568927. DOI: 10.1002/cncr.30826. View

17.

Macovei L, Burlui A, Bratoiu I, Rezus C, Cardoneanu A, Richter P . Adult-Onset Still's Disease-A Complex Disease, a Challenging Treatment. Int J Mol Sci. 2022; 23(21). PMC: 9655522. DOI: 10.3390/ijms232112810. View

18.

Fusco F, Pisapia R, Nardiello S, Cicala S, Gaeta G, Brancaccio G . Fever of unknown origin (FUO): which are the factors influencing the final diagnosis? A 2005-2015 systematic review. BMC Infect Dis. 2019; 19(1):653. PMC: 6647059. DOI: 10.1186/s12879-019-4285-8. View

19.

Mahr A, de Menthon M . Classification and classification criteria for vasculitis: achievements, limitations and prospects. Curr Opin Rheumatol. 2014; 27(1):1-9. DOI: 10.1097/BOR.0000000000000134. View

20.

Durack D, Street A . Fever of unknown origin--reexamined and redefined. Curr Clin Top Infect Dis. 1991; 11:35-51. View